Li YS - Search Results

1

Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X.

Li JJ, Wang Y, Nie SP, Li Q, Li YS, Huang Y, Hui RT. Li JJ, et al. Among authors: li q, li ys. Int J Cardiol. 2007 Oct 31;122(1):82-4. doi: 10.1016/j.ijcard.2006.11.031. Epub 2006 Dec 28. Int J Cardiol. 2007. PMID: 17196275 Clinical Trial.

2

Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.

Li JJ, Li YS, Chu JM, Zhang CY, Wang Y, Huang Y, Chen J, Yuan JQ, Huang YL. Li JJ, et al. Among authors: li ys. Clin Chim Acta. 2006 Apr;366(1-2):269-73. doi: 10.1016/j.cca.2005.10.021. Epub 2005 Dec 15. Clin Chim Acta. 2006. PMID: 16343471 Clinical Trial.

3

Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina.

Li JJ, Wang Y, Nie SP, Zhang CY, Li YS, Hui RT, Zhen X. Li JJ, et al. Among authors: li ys. Clin Chim Acta. 2007 Feb;376(1-2):163-7. doi: 10.1016/j.cca.2006.08.012. Epub 2006 Aug 16. Clin Chim Acta. 2007. PMID: 16999946 Clinical Trial.

4

Inflammation: a possible pathogenic link to cardiac syndrome X.

Li JJ, Li YS, Zhang Y, Gao Z, Li Z, Qian HY. Li JJ, et al. Among authors: li z, li ys. Med Hypotheses. 2006;66(1):87-91. doi: 10.1016/j.mehy.2005.08.005. Epub 2005 Sep 21. Med Hypotheses. 2006. PMID: 16182462

5

Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy.

Li JJ, Li YS, Chen J, Yang JQ. Li JJ, et al. Among authors: li ys. Med Hypotheses. 2006;66(6):1199-204. doi: 10.1016/j.mehy.2005.06.035. Epub 2006 Jan 18. Med Hypotheses. 2006. PMID: 16413682

6

Survival after alcohol septal ablation versus conservative therapy in obstructive hypertrophic cardiomyopathy.

Yang YJ, Fan CM, Yuan JQ, Qiao SB, Hu FH, Guo XY, Li YS. Yang YJ, et al. Among authors: li ys. Cardiol J. 2015;22(6):657-64. doi: 10.5603/CJ.a2015.0032. Epub 2015 Jun 23. Cardiol J. 2015. PMID: 26100829

7

The Prevalence and Long-Term Outcomes of Extreme Right versus Extreme Left Ventricular Hypertrophic Cardiomyopathy.

Guo X, Fan C, Wang H, Zhao S, Duan F, Wang Z, Yan L, Yang Y, An S, Li Y. Guo X, et al. Cardiology. 2016;133(1):35-43. doi: 10.1159/000439345. Epub 2015 Sep 29. Cardiology. 2016. PMID: 26414322

8

Comparison of Long-Term Outcome between Apical and Asymmetric Septal Hypertrophic Cardiomyopathy.

An S, Fan C, Yan L, Cai C, Yang Y, Zhai S, Zhao S, Liu Y, Duan F, Wang Z, Li Y. An S, et al. Cardiology. 2017;136(2):108-114. doi: 10.1159/000448239. Epub 2016 Sep 6. Cardiology. 2017. PMID: 27595481

9

Clinical Outcomes of Myocardial Bridging versus No Myocardial Bridging in Patients with Apical Hypertrophic Cardiomyopathy.

Zhai SS, Fan CM, An SY, Hang F, Yang YJ, Yan LR, Guo XY, Li YS. Zhai SS, et al. Among authors: li ys. Cardiology. 2018;139(3):161-168. doi: 10.1159/000486276. Epub 2018 Jan 31. Cardiology. 2018. PMID: 29393099

10

Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker?

Li N, Li Y, Wang F, Jiang W, Huang J, Xu Z, Hua L, Hua C, Huang Y, Wu Y, Li F. Li N, et al. Clin Cardiol. 2007 Sep;30(9):469-74. doi: 10.1002/clc.20150. Clin Cardiol. 2007. PMID: 17803204 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,787 results

Search Page

Filters